subject: UNII:9TD681796G

subject_name: Sitafloxacin

object_name: acute pyelonephritis


subject: UNII:9TD681796G

object_name: escherichia coli infection

tested_intervention: unsure


subject: CHEBI:4304

subject_name: sitafloxacin


subject: CHEBI:4304


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: hypotension

tested_intervention: yes


subject: CHEBI:85078

object_name: Hypotension, CTCAE


subject: GTOPDB:10492

subject_name: envafolimab

object_name: colon carcinoma


subject: GTOPDB:10492

object_name: colorectal cancer


subject: GTOPDB:10492

object_name: colon cancer


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:23724990

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:23724990

object_name: kidney failure


subject: PUBCHEM.COMPOUND:23724990

object_name: Coronary artery calcification


subject: PUBCHEM.COMPOUND:23724990

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:23724990

object_name: Vascular calcification


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: CHEBI:36796

subject_name: duloxetine

object_name: Drug Interactions


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: Post-Operative Pain


subject: CHEBI:66964

subject_name: Dronabinol


subject: UMLS:C1571394

object_name: autoinflammatory syndrome


subject: UMLS:C1571394

object_name: Schnitzler syndrome


subject: UMLS:C1571394

object_name: TNF receptor 1-associated periodic fever syndrome


subject: UMLS:C1571394

object_name: hyperimmunoglobulinemia D with periodic fever


subject: UMLS:C1571394

object_name: mevalonic aciduria


subject: CHEBI:94187

subject_name: Givinostat


subject: CHEBI:94187


subject: CHEBI:94187


subject: CHEBI:94187


subject: CHEBI:94187


subject: MESH:C077446

subject_name: Pikasol

object_name: heart failure


subject: MESH:C077446

object_name: Heart Failure, CTCAE


subject: MESH:C077446

object_name: myocardial infarction


subject: MESH:C077446

object_name: Myocardial Infarction, CTCAE


subject: MESH:C077446

object_name: Myocardial Infarction by ECG Finding


subject: MESH:C077446

object_name: atrial fibrillation


subject: MESH:C077446

object_name: Atrial Fibrillation by ECG Finding


subject: MESH:C077446

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVB Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVC Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IVA Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231679

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: trabecular adenocarcinoma


subject: CHEBI:72317

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:72317

object_name: skin neoplasm


subject: CHEBI:72317

object_name: skin cancer


subject: CHEBI:4875

subject_name: Etanercept

object_name: granulomatosis with polyangiitis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3897088

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3897088

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Suicide


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: borderline personality disorder


subject: CHEBI:5118


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: Dyslipidemia


subject: CHEBI:63716

object_name: Sustained Virologic Response


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:68606

subject_name: Rilpivirine


subject: CHEBI:68606


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: amyloidosis


subject: UMLS:C3826989


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Adverse anesthesia outcome


subject: CHEBI:2639

subject_name: Amiloride

object_name: heart failure


subject: CHEBI:2639

object_name: Heart Failure, CTCAE


subject: CHEBI:59243

subject_name: (R)-bendroflumethiazide


subject: CHEBI:59243


subject: CHEBI:3013

subject_name: Bendroflumethiazide


subject: CHEBI:3013


subject: CHEBI:93847

subject_name: Aceclidine

object_name: myopia


subject: CHEBI:93847

object_name: 1/3 meter (distance vision finding)


subject: CHEBI:93847

object_name: Miosis


subject: CHEBI:93847

object_name: Constricted pupil (finding)


subject: CHEBI:9241

subject_name: Spironolactone

object_name: hypoglycemia


subject: CHEBI:9241

object_name: Blood glucose below reference range (finding)


subject: CHEBI:9241

object_name: Hypoglycemia, CTCAE


subject: CHEBI:3360

subject_name: Cannabinol

object_name: osteoarthritis, knee


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: respiratory failure


subject: CHEBI:17061

object_name: bronchopulmonary dysplasia


subject: CHEBI:17061

object_name: Respiratory insufficiency


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:9241

object_name: liver cirrhosis


subject: CHEBI:9241

object_name: portal hypertension


subject: CHEBI:9241

object_name: Portal Hypertension, CTCAE


subject: CHEBI:31932

subject_name: olmesartan

object_name: Isolated systolic hypertension


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:59728

subject_name: desmopressin acetate trihydrate

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: CHEBI:59726

subject_name: desmopressin acetate (anhydrous)


subject: UMLS:C0086135

subject_name: DDAVP


subject: CHEBI:45409

subject_name: Ritonavir

object_name: Breastfeeding (mother)


subject: UMLS:C5557271

subject_name: Nicotine Oral Pouch

object_name: Tobacco-Related Carcinoma


subject: UMLS:C0040338

subject_name: Smokeless Tobacco


subject: MESH:C000627770

subject_name: folfirinox

object_name: Disseminated Malignant Neoplasm


subject: MESH:C000627770

object_name: Embolism, Tumor


subject: MESH:C000627770

object_name: Neoplasm Metastasis


subject: MESH:C000627770

object_name: intrahepatic cholangiocarcinoma


subject: MESH:C000627770

object_name: cirrhosis, familial


subject: MESH:C000627770

object_name: Radicular Cyst


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Failed Back Surgery Syndrome


subject: CHEBI:3077

object_name: Epiphysiolysis


subject: UMLS:C1657877

subject_name: Night Time brand of acetaminophen, dextromethorphan, doxylamine, and pseudoephedrine

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1657877

object_name: metabolic syndrome X


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Mechanical ventilation complication


subject: CHEBI:140621

object_name: Lung Injury


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915

object_name: adult acute respiratory distress syndrome


subject: CHEBI:119915


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931

object_name: respiratory failure


subject: CHEBI:6931

object_name: Respiratory Failure, CTCAE


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:44915

subject_name: Propofol

object_name: Critical Illness


subject: CHEBI:44915


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:3368

object_name: Crohn disease


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED


subject: UMLS:C1508867


subject: UNII:BRJ718SA03

object_name: osteoarthritis, knee


subject: UMLS:C2742997


subject: UNII:FA554TW3UP


subject: DRUGBANK:DB05050


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: HER2 protein overexpression


subject: CHEBI:175901

object_name: HER2 gene amplification


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:3423

subject_name: Carmustine

object_name: Mantle cell lymphoma stage III


subject: CHEBI:3423

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:3423

object_name: plasmablastic lymphoma


subject: CHEBI:3423

object_name: large-cell immunoblastic lymphoma


subject: CHEBI:3423

object_name: Follicular lymphoma stage III


subject: CHEBI:3423

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:3423

object_name: Follicle centre lymphoma, follicular grade I, II, III stage IV


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: multiple organ dysfunction syndrome


subject: CHEBI:6741

subject_name: Meloxicam

object_name: pharyngitis


subject: CHEBI:6741

object_name: Pharyngitis, CTCAE


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: renal cell carcinoma


subject: UMLS:C2718754

subject_name: Ilaris


subject: GTOPDB:10140

subject_name: spartalizumab


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: UMLS:C0721019

subject_name: IC-Green

object_name: non-small cell lung carcinoma


subject: UMLS:C0721019

object_name: Primary Neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C0879396

object_name: Childhood Breast Carcinoma


subject: UMLS:C0879396

object_name: breast carcinoma


subject: UMLS:C0879396

object_name: breast cancer


subject: UNII:A8E516A20K

subject_name: Talotrexin

object_name: leukemia


subject: UNII:A8E516A20K

object_name: childhood leukemia


subject: UNII:A8E516A20K

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:A8E516A20K

object_name: adult lymphoma


subject: UNII:A8E516A20K

object_name: lymphoma


subject: UNII:A8E516A20K

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:360682


subject: PUBCHEM.COMPOUND:360682


subject: PUBCHEM.COMPOUND:360682


subject: PUBCHEM.COMPOUND:360682


subject: PUBCHEM.COMPOUND:360682


subject: PUBCHEM.COMPOUND:360682


subject: CHEBI:52717

subject_name: Bortezomib

object_name: neoplasm of mature T-cells or NK-cells


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: sarcopenia


subject: UMLS:C1170120

subject_name: Caphosol

object_name: Oral Mucositis


subject: UMLS:C1170120

object_name: stomatitis


subject: UMLS:C1170120

object_name: oral mucositis


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404

object_name: precancerous condition


subject: DRUGBANK:DB01404

object_name: unspecified adult solid tumor, protocol specific


subject: DRUGBANK:DB01404

object_name: myeloproliferative neoplasm


subject: DRUGBANK:DB01404

object_name: lymphoproliferative syndrome


subject: DRUGBANK:DB01404

object_name: Myelodysplasia


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole

object_name: Fatigue, CTCAE 5.0


subject: DRUGBANK:DB14296

object_name: Fatigue


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: DRUGBANK:DB14296


subject: UNII:2ROQ545LAG

subject_name: Bezuclastinib

object_name: indolent systemic mastocytosis


subject: UNII:2ROQ545LAG

object_name: aggressive systemic mastocytosis


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: portal hypertension


subject: CHEBI:78770

object_name: Portal Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:2724258


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459


subject: CHEBI:31765

subject_name: Laureth 4


subject: CHEBI:31765


subject: UMLS:C1263450

subject_name: lauromacrogols


subject: UMLS:C1263450


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: celiac disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:91872

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:91872

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:91872

object_name: Bladder cancer stage IV


subject: CHEBI:91872

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:91872

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:91872

object_name: Bladder cancer recurrent


subject: CHEBI:91872

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:91872

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:91872

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:91872

object_name: Distal Urethral Carcinoma


subject: CHEBI:91872

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:91872

object_name: Recurrent Urethral Cancer


subject: CHEBI:91872

object_name: posterior urethra cancer


subject: CHEBI:91872

object_name: Proximal Urethral Carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: transitional cell carcinoma


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: CHEBI:132922

object_name: Distal Radius Fractures


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Prevention problem


subject: CHEBI:2948

object_name: Recurrence


subject: CHEBI:2948

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:2948

object_name: Recurrent tumor


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Parkinson disease


subject: UNII:X587FW0372

object_name: Lewy Bodies


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid


subject: CHEBI:17290


subject: CHEBI:37054


subject: CHEBI:37054


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: DRUGBANK:DB14248

subject_name: Bos taurus gallstone

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:83766

subject_name: Olaparib

object_name: Recurrent Metastatic Melanoma


subject: CHEBI:83766

object_name: mucosal melanoma


subject: CHEBI:83766

object_name: melanoma


subject: CHEBI:83766

object_name: skin melanoma


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Epilepsy, unspecified, refractory (medically)


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: cervical cancer


subject: UNII:M487QF2F4V

object_name: cervical carcinoma


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: Wound Infection


subject: PUBCHEM.COMPOUND:21014972

object_name: cellulitis


subject: PUBCHEM.COMPOUND:21014972

object_name: cellulitis on exam (physical finding)


subject: PUBCHEM.COMPOUND:21014972

object_name: abscess


subject: PUBCHEM.COMPOUND:21014972

object_name: ulcer disease


subject: PUBCHEM.COMPOUND:21014972

object_name: Burn injury


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: photosensitive epilepsy


subject: CHEBI:5000

subject_name: Fenfluramine


subject: PUBCHEM.COMPOUND:46874763

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:46874763

object_name: Bacterial sepsis of newborn


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Colon Neoplasm


subject: UNII:M0Q7802G2B

subject_name: Benzodiazepines

object_name: substance-related disorder


subject: UMLS:C4048284

subject_name: Benzodiazepine


subject: UMLS:C3536850

subject_name: Benzodiazepine [EPC]


subject: CHEBI:63453

object_name: Childhood Breast Carcinoma


subject: CHEBI:63453

object_name: breast cancer


subject: PUBCHEM.COMPOUND:16208013

subject_name: Tecemotide

object_name: plasma cell myeloma


subject: UNII:Q7Y026G2CX

subject_name: TECEMOTIDE


subject: UMLS:C1832016


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Nontuberculous mycobacterial infection


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Substance Use Disorders


subject: CHEBI:32682

subject_name: L-argininium

object_name: qualitative or quantitative defects of dystrophin


subject: CHEBI:32682

object_name: Becker muscular dystrophy


subject: CHEBI:32682

object_name: Duchenne muscular dystrophy


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: DRUGBANK:DB17956

object_name: Parkinson disease


subject: CHEBI:193615

object_name: Unresectable Colorectal Carcinoma


subject: CHEBI:193615

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:193615

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: UMLS:C3640063

subject_name: Liposomal MUC1/PET-lipid A Vaccine ONT-10

object_name: Solid Neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Malignant melanoma stage II


subject: UMLS:C2346820


subject: CHEBI:66889

subject_name: Peginesatide

object_name: pure red-cell aplasia


subject: UMLS:C1710272

subject_name: hematide


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456

object_name: breast carcinoma


subject: CHEBI:6456


subject: CHEBI:135948

subject_name: Amifampridine

object_name: botulism


subject: CHEBI:135948

object_name: Poisoning caused by Clostridium botulinum toxin


subject: CHEBI:135948

object_name: iatrogenic botulism


subject: UMLS:C1714033

subject_name: wheat dextrin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1714033

object_name: obesity


subject: UMLS:C1714033

object_name: Obesity, CTCAE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: euthyroid Graves orbitopathy


subject: CHEBI:39548

object_name: endocrine exophthalmos


subject: CHEBI:27808

subject_name: Diamorphine

object_name: opiate dependence


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: traumatic encephalopathy


subject: CHEBI:3387

object_name: traumatic brain injury


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: systolic heart failure


subject: CHEBI:15927

object_name: Heart failure NYHA class IV


subject: CHEBI:30746

subject_name: Benzoic acid

object_name: schizophrenia


subject: CHEBI:30746

object_name: schizophreniform disorder


subject: CHEBI:30746

object_name: schizoaffective disorder


subject: CHEBI:30746

object_name: schizophrenia 18


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Torticollis


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C4758796

object_name: non-small cell lung carcinoma


subject: CHEBI:3423

subject_name: Carmustine

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5557596

subject_name: Myc Inhibitor OMO-103

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5557596

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5557596

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C5557596

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C5557596

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:79699

object_name: diffuse intrinsic pontine glioma


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UMLS:C5226694

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5226694

object_name: amyotrophic lateral sclerosis


subject: UMLS:C3493834

object_name: ulcerative colitis


subject: UMLS:C3493834

object_name: inflammatory bowel disease 1


subject: UMLS:C0122184

subject_name: HOE 490

object_name: type 2 diabetes mellitus


subject: CHEBI:7773

subject_name: Ondansetron

object_name: atrial fibrillation


subject: CHEBI:7773

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:7773

object_name: Atrial Fibrillation, CTCAE


subject: PR:000004614

subject_name: bile acid-CoA:amino acid N-acyltransferase

object_name: Adenocarcinoma of the prostate metastatic


subject: PR:000004614

object_name: prostate adenocarcinoma


subject: CHEBI:5931

subject_name: insulin human

object_name: complete trisomy 21


subject: CHEBI:5931

object_name: Down syndrome


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:31355

subject_name: Carboplatin

object_name: skin neoplasm


subject: CHEBI:31355

object_name: skin cancer


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: plantar fasciitis


subject: CHEBI:8426

subject_name: Probenecid

object_name: Drug Interactions


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: conjunctival cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C2000258

object_name: skin melanoma


subject: UMLS:C2000258

object_name: ocular melanoma


subject: UMLS:C2000258

object_name: uveal melanoma


subject: UMLS:C2000258


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: DRUGBANK:DB18535


subject: DRUGBANK:DB18535

object_name: rheumatoid arthritis


subject: CHEBI:16302


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C5698587

subject_name: Rice Protein Concentrate

object_name: Food intolerance


subject: UMLS:C5698587

object_name: food intolerance (history)


subject: UNII:VM4G5D1A60

subject_name: LADIRATUZUMAB VEDOTIN

object_name: prostate carcinoma


subject: UNII:VM4G5D1A60

object_name: prostate cancer


subject: UNII:VM4G5D1A60

object_name: small cell lung carcinoma


subject: UNII:VM4G5D1A60

object_name: non-small cell squamous lung carcinoma


subject: UNII:VM4G5D1A60

object_name: head and neck squamous cell carcinoma


subject: UNII:VM4G5D1A60


subject: UNII:VM4G5D1A60

object_name: esophageal squamous cell carcinoma


subject: UNII:VM4G5D1A60

object_name: gastric adenocarcinoma


subject: UNII:VM4G5D1A60

object_name: melanoma


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C3827076


subject: UMLS:C2984518

subject_name: tabalumab

object_name: EXCESS LMW-DNA


subject: UMLS:C2984518

object_name: Rheumatism


subject: UMLS:C2984518

object_name: connective tissue disorder


subject: UMLS:C2984518

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: UMLS:C2984518

object_name: Autoimmunity


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Knee arthropathy


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: lung cancer


subject: CHEBI:32016

object_name: lung neoplasm


subject: CHEBI:32016

object_name: lung carcinoma


subject: CHEBI:5384

subject_name: Glipizide

object_name: chronic kidney disease


subject: CHEBI:52172

subject_name: Nilotinib

object_name: colorectal carcinoma


subject: CHEBI:52172

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:52172

object_name: Neck Carcinoma


subject: CHEBI:52172

object_name: head and neck neoplasm


subject: CHEBI:52172

object_name: head and neck cancer


subject: UMLS:C3641684

object_name: breast neoplasm


subject: UMLS:C1710461

subject_name: Cyclokapron

object_name: hereditary von Willebrand disease


subject: UMLS:C1710461

object_name: von Willebrand disease (hereditary or acquired)


subject: UMLS:C1710461

object_name: hemophilia A


subject: UMLS:C1710461

object_name: hemophilia


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:91414

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:91414

object_name: ovarian Brenner tumor


subject: CHEBI:91414

object_name: ovarian carcinosarcoma


subject: CHEBI:91414

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:91414

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:91414

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:91414

object_name: ovarian seromucinous carcinoma


subject: CHEBI:91414

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:91414

object_name: ovarian serous surface papillary adenocarcinoma


subject: CHEBI:91414

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: retinal vein occlusion


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine

object_name: lung cancer


subject: UNII:0NIZ8H6OL8

object_name: lung carcinoma


subject: UNII:0NIZ8H6OL8

object_name: non-small cell lung carcinoma


subject: UMLS:C3275040

object_name: glioma


subject: UMLS:C3275040

object_name: malignant glioma


subject: UMLS:C3272771

subject_name: Topical Piperidine Nitroxide MTS-01

object_name: alopecia


subject: UMLS:C3272771

object_name: Alopecia, CTCAE


subject: UMLS:C1176324

object_name: prostate carcinoma


subject: UMLS:C1176324

object_name: prostate cancer


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Congenital hip dislocation


subject: CHEBI:6923

subject_name: Miconazole

object_name: otomycosis


subject: UMLS:C3541397

subject_name: oil ingredients


subject: MESH:D009821

subject_name: Oils


subject: CHEMBL.COMPOUND:CHEMBL2109152

subject_name: MINERAL OIL


subject: PUBCHEM.COMPOUND:139291139

subject_name: Mineral oil


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: EXCESS LMW-DNA


subject: UMLS:C4760689

subject_name: Cyclophosphamide for Injection

object_name: liver carcinoma


subject: UMLS:C4760729

subject_name: Fludarabine Phosphate for Injection


subject: UMLS:C2350618

subject_name: AGO 178

object_name: Hepatic impairment


subject: CHEBI:33699

subject_name: messenger RNA

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:33699

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:33699

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:33699

object_name: plasma cell myeloma


subject: CHEBI:33699

object_name: adult lymphoma


subject: CHEBI:33699

object_name: lymphoma


subject: CHEBI:33699

object_name: pediatric lymphoma


subject: CHEBI:33699

object_name: leukemia


subject: CHEBI:33699

object_name: childhood leukemia


subject: CHEBI:38867

subject_name: anaesthetic

object_name: Anaesthesia intubation complication


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: CHEBI:45267

subject_name: praziquantel

object_name: cysticercosis


subject: CHEBI:45267

object_name: Neurocysticercosis


subject: CHEBI:45267

object_name: Central Nervous System Cysticercosis


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:91583


subject: CHEBI:91583


subject: UNII:04XPW8C0FL

subject_name: Aprotinin

object_name: myocardial ischemia


subject: UNII:04XPW8C0FL

object_name: Family history of ischemic heart disease


subject: UNII:04XPW8C0FL

object_name: Angina pectoris


subject: CHEBI:80489

subject_name: desmethylxanthohumol

object_name: Inflammatory Response


subject: CHEBI:66331

subject_name: Xanthohumol


subject: CHEBI:7565

subject_name: Nifedipine

object_name: diabetic kidney disease


subject: UMLS:C3474499

subject_name: Goji berry preparation

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:3962

object_name: rheumatoid arthritis


subject: CHEBI:40303

subject_name: Lovastatin


subject: UMLS:C3896694

subject_name: MAGE-A3-expressing Adenovirus Type 5 Vaccine

object_name: skin squamous cell carcinoma


subject: UMLS:C3896694

object_name: metastatic melanoma


subject: CHEBI:7457

subject_name: Nalmefene

object_name: Cirrhosis


subject: CHEBI:7457

object_name: liver cirrhosis


subject: UMLS:C0721019

subject_name: IC-Green

object_name: melanoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: lung disorder


subject: GTOPDB:12990

subject_name: sintilimab

object_name: pathological complete response


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: tumor of uterus


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C2587184

subject_name: Parenogen

object_name: Transfusion-Related Acute Lung Injury


subject: UMLS:C2587184

object_name: Transfusion associated circulatory overload


subject: UMLS:C2587184

object_name: Surgery--Complications


subject: UMLS:C2587184

object_name: Cardiac defects


subject: UMLS:C2587184

object_name: acquired; fibrinogenopenia


subject: UMLS:C2587184

object_name: congenital heart disease


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE


subject: UNII:RZ22DI43TP


subject: UNII:RZ22DI43TP


subject: UNII:RZ22DI43TP


subject: UNII:RZ22DI43TP


subject: UNII:RZ22DI43TP


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Reperfusion Injury


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: Spontaneous intracranial hemorrhage


subject: CHEBI:36088

object_name: hypertension


subject: CHEBI:36088

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Knee arthropathy


subject: PUBCHEM.COMPOUND:92043599

object_name: Hip arthropathy


subject: PUBCHEM.COMPOUND:92043599

object_name: anemia due to chronic disorder


subject: UMLS:C2703179

subject_name: MLF 541

object_name: digestive system cancer


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: interstitial lung disease


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:171390277

object_name: Conn's syndrome


subject: UMLS:C5707295

subject_name: Fluorine F 18 Para-chloro-2-fluoroethyl-etomidate


subject: CHEBI:5959

subject_name: Irbesartan

object_name: type 2 diabetes mellitus


subject: CHEBI:5959

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C2981231

subject_name: fulranumab

object_name: neuralgia


subject: UMLS:C2981231

object_name: Neuralgia, CTCAE


subject: UMLS:C2981231

object_name: postherpetic neuralgia


subject: UMLS:C2981231

object_name: mononeuropathy


subject: CHEBI:9150

subject_name: Simvastatin

object_name: mild neurocognitive disorder


subject: CHEBI:9150

object_name: mild cognitive impairment


subject: CHEBI:10033

subject_name: Warfarin

object_name: pancreatic neoplasm


subject: CHEBI:10033

object_name: exocrine pancreatic carcinoma


subject: CHEBI:10033

object_name: malignant pancreatic neoplasm


subject: CHEBI:31348

subject_name: Capecitabine

object_name: brain stem glioma


subject: CHEBI:135901

subject_name: lanreotide

object_name: Gastrointestinal motility disorder


subject: CHEBI:135901

object_name: intestinal disorder


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C0051846


subject: UNII:S0N1VEG94I

subject_name: Sivopixant

object_name: sleep apnea


subject: UNII:S0N1VEG94I

object_name: Sleep Apnea, CTCAE


subject: UMLS:C5966119

subject_name: CDK2 Inhibitor AVZO-021

object_name: CCNE1 Gene Amplification


subject: UMLS:C5966119

object_name: endometrial cancer


subject: UMLS:C5966119

object_name: uterine corpus cancer


subject: UMLS:C5966119

object_name: endometrial carcinoma


subject: UMLS:C5966119

object_name: triple-negative breast carcinoma


subject: UMLS:C5966119

object_name: ovarian carcinoma


subject: UMLS:C5966119

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5966119

object_name: primary peritoneal carcinoma


subject: UMLS:C5966119

object_name: Primary Peritoneal Cancer


subject: UMLS:C5966119

object_name: fallopian tube carcinoma


subject: UMLS:C5966119

object_name: fallopian tube cancer


subject: CHEBI:233362

subject_name: Abemaciclib


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UMLS:C5434105


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:142433

subject_name: Cinaciguat

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:142433

object_name: Acute heart failure


subject: CHEBI:16302

object_name: Disorder of olfactory system


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532

object_name: ovarian cancer


subject: CHEBI:6532

object_name: ovarian neoplasm


subject: CHEBI:6532


subject: PUBCHEM.COMPOUND:23616699

subject_name: hyoscine-N-butylbromide


subject: PUBCHEM.COMPOUND:23616699


subject: PUBCHEM.COMPOUND:23616699


subject: PUBCHEM.COMPOUND:23616699


subject: PUBCHEM.COMPOUND:23616699


subject: PUBCHEM.COMPOUND:23616699


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: peritoneal neoplasm


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:37845

subject_name: growth hormone

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Chronic liver disease


subject: UMLS:C3854029

object_name: Cirrhosis


subject: UMLS:C3854029

object_name: liver cirrhosis


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: UNII:7KKS9R192F

subject_name: Gimatecan

object_name: peritoneum cancer


subject: UNII:7KKS9R192F

object_name: ovarian carcinoma


subject: UNII:7KKS9R192F

object_name: malignant epithelial tumor of ovary


subject: UNII:7KKS9R192F

object_name: fallopian tube carcinoma


subject: UNII:7KKS9R192F

object_name: fallopian tube cancer


subject: CHEBI:4910

subject_name: Etomidate

object_name: postpartum hemorrhage


subject: CHEBI:4910

object_name: Post-partum hemorrhage


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: GTOPDB:11552

subject_name: ziltivekimab

object_name: Inflammation


subject: GTOPDB:11552

object_name: arteriosclerosis disorder


subject: GTOPDB:11552

object_name: atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL4297732

subject_name: ZILTIVEKIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297732


subject: CHEMBL.COMPOUND:CHEMBL4297732


subject: UMLS:C5419333


subject: UMLS:C5419333


subject: UMLS:C5419333


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: cryoglobulinemia


subject: UNII:73B0K5S26A

object_name: vasculitis


subject: UNII:73B0K5S26A

object_name: Vasculitis, CTCAE


subject: UMLS:C2985186

object_name: diabetes mellitus


subject: DRUGBANK:DB11050

subject_name: Typhoid Vaccine Live

object_name: typhoid fever


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: Irritable heart


subject: CHEBI:90942

subject_name: Ixazomib

object_name: solitary osseous plasmacytoma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:71416

subject_name: phenazopyridine

object_name: Postoperative retention of urine


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: arthritis


subject: CHEBI:41879

object_name: Arthritis, CTCAE


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: c.surgical procedure; gastrointestinal


subject: CHEBI:41879


subject: CHEBI:149509

object_name: diabetic kidney disease


subject: CHEBI:3347

subject_name: Candesartan


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Acute-On-Chronic Liver Failure


subject: PUBCHEM.COMPOUND:66964417

object_name: acute-on-chronic liver failure


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin


subject: PUBCHEM.COMPOUND:46783403


subject: CHEBI:17234

subject_name: D-glucose

object_name: Lesion, Superficial Radial Nerve


subject: CHEBI:15372

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:18258

subject_name: Liothyronine

object_name: endocrine system disorder


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: immune-mediated adverse reaction


subject: PR:000014196

object_name: acute leukemia


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5392068


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Non-small cell lung cancer stage II


subject: CHEBI:4672

object_name: Non-small cell lung cancer stage I


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:231679

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C4018781

subject_name: human milk preparation

object_name: Disorder of transplanted kidney


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: abortion; medical, fetus


subject: CHEBI:15551

object_name: incomplete abortion


subject: CHEBI:15551

object_name: Missed abortion


subject: UMLS:C0356637

subject_name: Gemeprost 1 mg vaginal pessary


subject: UMLS:C0356637


subject: UMLS:C0356637


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: traumatic encephalopathy


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Chronic Traumatic Encephalopathy


subject: CHEBI:65136

subject_name: Osbond acid


subject: CHEBI:65136


subject: CHEBI:34936

subject_name: propanil


subject: CHEBI:34936


subject: CHEBI:53488


subject: CHEBI:53488


subject: CHEBI:4640

subject_name: diphenylamine


subject: CHEBI:4640


subject: CHEBI:51676


subject: CHEBI:51676


subject: CHEBI:23757

subject_name: dihydrophaseic acid


subject: CHEBI:23757


subject: CHEBI:39867

subject_name: Valproic acid


subject: MESH:D002214

subject_name: Capsules


subject: MESH:D002214


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: renal cell carcinoma


subject: UNII:FN12T66RMN

subject_name: EFPREZIMOD ALFA

object_name: acute graft versus host disease


subject: UNII:FN12T66RMN

object_name: Myelodysplasia


subject: UNII:FN12T66RMN

object_name: acute myeloid leukemia by FAB classification


subject: UNII:FN12T66RMN

object_name: acute myeloid leukemia


subject: UNII:FN12T66RMN

object_name: acute lymphoblastic leukemia


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: CHEBI:15365

subject_name: Aspirin

object_name: autoimmune thrombocytopenia


subject: CHEBI:15365

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:15365

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:90225

subject_name: Rubitecan

object_name: carcinoma of urethra


subject: CHEBI:90225

object_name: urethra cancer


subject: CHEBI:90225

object_name: bladder tumor


subject: CHEBI:90225

object_name: urinary bladder carcinoma


subject: CHEBI:90225

object_name: urinary bladder cancer


subject: CHEBI:90225

object_name: childhood bladder carcinoma


subject: CHEBI:90225

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Renal Colic, CTCAE


subject: CHEBI:6456

object_name: renal colic


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: retinal vein occlusion


subject: UMLS:C2352201

subject_name: Conbercept


subject: CHEBI:229764

subject_name: Selinexor

object_name: Childhood Glioblastoma


subject: CHEBI:229764

object_name: adult glioblastoma


subject: CHEBI:229764

object_name: Adult Gliosarcoma


subject: CHEBI:229764

object_name: gliosarcoma


subject: CHEBI:229764

object_name: Childhood Gliosarcoma


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Androgen excess


subject: GTOPDB:4391

subject_name: LH

object_name: Progesterone level


subject: CHEBI:74539

subject_name: Leu-His


subject: CHEBI:81568

subject_name: luteinizing hormone


subject: GTOPDB:1160

subject_name: hCG


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C3884615

object_name: ankylosing spondylitis


subject: UMLS:C3884615

object_name: psoriatic arthritis


subject: UMLS:C5440675

subject_name: Qwo

object_name: Cellulite


subject: CHEBI:95001

subject_name: Dalcetrapib


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: infertility


subject: UMLS:C5706445

subject_name: RAS Inhibitor RMC-6236

object_name: Matthew-Wood syndrome


subject: UMLS:C5706445

object_name: pancreatic neoplasm


subject: UMLS:C5706445

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706445

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: small intestine disorder


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: chronic hepatitis B virus infection


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C1831888


subject: UMLS:C1831888


subject: UMLS:C1831888


subject: UMLS:C1831888

object_name: pancreatic adenocarcinoma


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UNII:FR2W015BG1

object_name: atherosclerosis


subject: UMLS:C2981824


subject: CHEBI:77590

subject_name: Armodafinil

object_name: non-small cell lung carcinoma


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:3219

subject_name: Bupropion


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: CHEBI:22586

subject_name: antioxidant

object_name: Photodamaged skin


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0733521

subject_name: Ara-C

object_name: Refractory acute myeloid leukemia


subject: UMLS:C1541476

subject_name: AMG 706

object_name: Solid Neoplasm


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: thrombotic microangiopathy


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation

object_name: Child Malnutrition


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: squamous cell carcinoma


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate

object_name: Chronic pain


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: PUBCHEM.COMPOUND:105162

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:105162

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:105162

object_name: Clear-cell metastatic renal cell carcinoma


subject: UMLS:C5555594

subject_name: Lutetium Lu-177 PNT2002


subject: UMLS:C5555594


subject: UMLS:C5555594


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: hepatitis A


subject: CHEBI:59902

object_name: tuberculosis


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: UMLS:C3896796

subject_name: narsoplimab

object_name: atypical hemolytic-uremic syndrome


subject: CHEMBL.COMPOUND:CHEMBL4298195

subject_name: NARSOPLIMAB


subject: CHEMBL.COMPOUND:CHEMBL4298195


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: liver failure


subject: CHEBI:73604

object_name: Mechanical ventilation finding


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Advanced lung cancer


subject: UNII:28X28X9OKV

object_name: Non-small cell lung cancer recurrent


subject: UNII:28X28X9OKV

object_name: Carcinoma of respiratory tract and intrathoracic organs


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Blood Pressure Finding


subject: CHEBI:81579

object_name: Systemic arterial pressure


subject: UMLS:C1735933

subject_name: Clindamycin, Vaginal

object_name: bacterial infectious disease


subject: CHEBI:95165

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:95165

object_name: clear cell renal carcinoma


subject: CHEBI:95165

object_name: renal cell adenocarcinoma


subject: CHEBI:95165

object_name: renal cell carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UNII:43K1W2T1M6


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625


subject: UMLS:C5552625


subject: UMLS:C5552625


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Low back pain


subject: CHEBI:66964

object_name: Back Injuries


subject: CHEBI:18248

subject_name: Iron

object_name: Premature birth


subject: UMLS:C4282332

object_name: Myelodysplasia


subject: UMLS:C4282332

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4282332

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4282332

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4282332

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4282332

object_name: acute myeloid leukemia


subject: UMLS:C4282332

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:8499

subject_name: Propranolol

object_name: myocardial infarction


subject: CHEBI:8499

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:8499

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:8499

object_name: heart disorder


subject: CHEBI:8499

object_name: cardiac conduction defect


subject: CHEBI:8499

object_name: coronary artery disorder


subject: CHEBI:8499

object_name: myocardial ischemia


subject: CHEBI:8499

object_name: coronary atherosclerosis


subject: CHEBI:8499

object_name: cardiovascular disorder


subject: CHEBI:8499

object_name: ventricular fibrillation


subject: CHEBI:8499

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:8499

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:8499

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:8499

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: GTOPDB:10752

subject_name: leronlimab

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109343

subject_name: LERONLIMAB


subject: UMLS:C3179325

subject_name: PRO 140


subject: CHEBI:49960

subject_name: Vandetanib

object_name: prostate carcinoma


subject: CHEBI:49960

object_name: prostate cancer


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: herpes simplex encephalitis


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: lung cancer


subject: UMLS:C2830069

object_name: lung neoplasm


subject: UMLS:C2830069

object_name: lung carcinoma


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:229764

subject_name: Selinexor

object_name: Stage IV Adult Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Stage IV Childhood Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Stage III Childhood Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Stage III Adult Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:229764

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:229764

object_name: Mantle cell lymphoma refractory


subject: CHEBI:229764

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:229764

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:229764

object_name: Follicular lymphoma refractory


subject: CHEBI:229764

object_name: Follicular lymphoma recurrent


subject: CHEBI:229764

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:229764


subject: CHEBI:59729

subject_name: fenfluramine hydrochloride

object_name: epilepsy


subject: GTOPDB:9517

subject_name: atacicept

object_name: multicentric Castleman disease


subject: GTOPDB:9517

object_name: multicentric Castleman disease, susceptibility to


subject: GTOPDB:9517

object_name: multiple carboxylase deficiency


subject: GTOPDB:9517

object_name: macular corneal dystrophy


subject: GTOPDB:9517

object_name: nephrotic syndrome


subject: GTOPDB:9517

object_name: Nephrotic Syndrome, CTCAE


subject: GTOPDB:9517

object_name: focal segmental glomerulosclerosis


subject: GTOPDB:9517

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: CHEMBL.COMPOUND:CHEMBL1742986


subject: UMLS:C2351058

subject_name: Atacicept


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C2351058


subject: UMLS:C4305805

object_name: hepatitis C


subject: UMLS:C4305805

object_name: chronic hepatitis C virus infection


subject: UMLS:C4305805

object_name: viral hepatitis


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Rett syndrome


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: UMLS:C5575682

subject_name: Kefir antigen

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C5575682

object_name: metabolic syndrome X


subject: UMLS:C5575682

object_name: hypertension


subject: UMLS:C5575682

object_name: Hypertension, CTCAE


subject: UMLS:C5575682

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5575682

object_name: obesity


subject: UMLS:C5575682

object_name: Obesity, CTCAE


subject: UMLS:C5575682

object_name: hyperlipidemia


subject: UMLS:C5575682

object_name: type 2 diabetes mellitus


subject: UMLS:C5575682

object_name: Insulin resistance


subject: UMLS:C3257524

subject_name: cultivated mushroom extract

object_name: Prediabetes


subject: UMLS:C3257524


subject: UMLS:C3257524


subject: UMLS:C3257524

object_name: vitamin D deficiency


subject: DRUGBANK:DB10544

subject_name: Cultivated mushroom


subject: DRUGBANK:DB10544


subject: DRUGBANK:DB10544


subject: DRUGBANK:DB10544


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Untreated Childhood Brain Stem Glioma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: acute liver failure


subject: UNII:VF9KM790TY

object_name: Atopic rhinitis


subject: UNII:VF9KM790TY

object_name: Allergic Rhinitis, CTCAE


subject: UNII:2BOD5IUD08


subject: UNII:2BOD5IUD08


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: graft versus host disease


subject: UNII:25E79B5CTM

object_name: immune system disorder


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:4875

subject_name: Etanercept


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Refractory Primary Peritoneal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Refractory Ovarian Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Refractory Fallopian Tube Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Sensitive Primary Peritoneal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Sensitive Fallopian Tube Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C3899995

subject_name: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes


subject: UMLS:C3899995

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C3899995

object_name: Recurrent ovarian cancer


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:149509

object_name: aortic valve disease 2


subject: CHEBI:149509

object_name: aortic stenosis


subject: CHEBI:149509

object_name: aortic valve disease 3


subject: CHEBI:149509

object_name: Stenosis of aorta


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Metastatic urothelial carcinoma


subject: MESH:C559761

subject_name: pentoxifylline-tocopherol-clodronate

object_name: Osteoradionecrosis of jaw


subject: UMLS:C3640820

subject_name: Saccharomyces boulardii Probiotic Supplement

object_name: Cirrhosis


subject: UMLS:C3640820

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin

object_name: Burn injury


subject: PUBCHEM.COMPOUND:266052

object_name: Burn, CTCAE


subject: UMLS:C0556112

subject_name: Mineral supplements


subject: UMLS:C0556112


subject: CHEBI:17698

subject_name: Chloramphenicol

object_name: schizophrenia


subject: CHEBI:5441

subject_name: Glyburide

object_name: Cerebral Blood Flow


subject: UMLS:C5227659

object_name: cystic fibrosis


subject: UMLS:C0008586

subject_name: Chromogranins

object_name: cesarean section; complications


subject: UMLS:C0008586

object_name: Wound Breakdown


subject: UMLS:C0008586

object_name: Wound Infection


subject: UMLS:C0008586

object_name: Wound Infection, CTCAE


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:145371

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:78122784

subject_name: Tenapanor

object_name: synucleinopathy


subject: PUBCHEM.COMPOUND:78122784

object_name: Parkinson disease


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:3JGY52XJNA

subject_name: Lutropin alfa

object_name: female infertility


subject: CHEBI:177492

subject_name: Cositecan

object_name: primary peritoneal carcinoma


subject: CHEBI:177492

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:177492

object_name: peritoneal carcinoma


subject: CHEBI:177492

object_name: Recurrent ovarian cancer


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:OS7097575K

object_name: B-cell neoplasm


subject: UMLS:C3485429

subject_name: Probiotic Formula


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: AIDS


subject: CHEBI:421707

subject_name: Abacavir


subject: PR:000023218

subject_name: methionine import ATP-binding protein MetN


subject: CHEBI:73501

subject_name: Glu-Phe-Val


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin

object_name: thrombophlebitis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Acute Ischemic Stroke


subject: CHEBI:4466

object_name: Ischemic stroke


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: breast disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UNII:Q830PW7520

subject_name: CODEINE


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C1948073

object_name: skin melanoma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: polyneuropathy


subject: CHEBI:6339

object_name: peripheral nerve injury


subject: CHEBI:6339

object_name: radiculopathy


subject: CHEBI:6339

object_name: causalgia


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: diffuse large B-cell lymphoma


subject: CHEBI:231673

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:231673

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:74800

subject_name: Pro-Val


subject: CHEBI:74800


subject: CHEBI:74800


subject: CHEBI:27446

subject_name: Penicillin V


subject: CHEBI:27446


subject: CHEBI:27446


subject: UMLS:C1514791

subject_name: Recombinant Vaccinia-CEA

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: myopathy


subject: UMLS:C0037668

object_name: cystinosis


subject: CHEBI:28918

subject_name: Epinephrine

object_name: polyp of colon


subject: UMLS:C4727207

subject_name: Nidanilimab

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: MESH:C000627770

subject_name: folfirinox


subject: CHEBI:62880

subject_name: Veliparib

object_name: malignant glioma


subject: CHEBI:62880

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:62880

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:62880

object_name: anaplastic astrocytoma


subject: CHEBI:62880

object_name: glioblastoma


subject: CHEBI:62880

object_name: adult glioblastoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Brain Stem Glioblastoma


subject: CHEBI:70839

object_name: glioma susceptibility 1


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:5C69YCD2YJ

subject_name: CARRAGEENAN

object_name: type 2 diabetes mellitus


subject: UNII:5C69YCD2YJ

object_name: Insulin resistance


subject: CHEBI:3435

subject_name: carrageenan


subject: CHEBI:3435


subject: CHEMBL.COMPOUND:CHEMBL4802180

subject_name: RECOMBINANT HUMAN THROMBOPOIETIN

object_name: Delayed platelet engraftment


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin


subject: UMLS:C5847502

subject_name: Agave Inulin

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:3025707

subject_name: Sunphenon

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:3025707

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:3025707

object_name: prostate adenocarcinoma


subject: CHEBI:4806

subject_name: Epigallocatechin gallate


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:84040

object_name: Inflammation


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:74224

object_name: prostate neoplasm


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:28088

subject_name: Genistein


subject: UNII:8WE94VAO6U

subject_name: chiglitazar

object_name: kidney failure


subject: CHEBI:32682

subject_name: L-argininium

object_name: intermittent vascular claudication


subject: CHEBI:32682

object_name: peripheral vascular disease


subject: CHEBI:32682

object_name: peripheral arterial disease


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:63450

subject_name: Masitinib

object_name: ovarian cancer


subject: CHEBI:63450

object_name: ovarian neoplasm


subject: CHEBI:63450

object_name: ovarian carcinoma


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Hodgkin Disease


subject: UMLS:C1541395


subject: UMLS:C2077029

subject_name: inhaled budesonide

object_name: radiation pneumonitis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: euthyroid Graves orbitopathy


subject: CHEBI:41423

object_name: endocrine exophthalmos


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: High grade glioma


subject: CHEBI:90001

object_name: malignant glioma


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: interstitial cystitis


subject: UMLS:C1172157


subject: CHEBI:29998

subject_name: D-serine residue

object_name: Depressed mood


subject: CHEBI:29998

object_name: Cancer patients and suicide and depression


subject: CHEBI:29998

object_name: Depressed - symptom


subject: CHEBI:29998

object_name: Depression, CTCAE


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: CHEBI:17115


subject: CHEBI:17115


subject: UMLS:C1880218

subject_name: serine, D-


subject: UMLS:C1880218


subject: UMLS:C1880218


subject: UMLS:C1880218


subject: CHEBI:85361

subject_name: tetramethylsilane


subject: CHEBI:85361


subject: CHEBI:85361


subject: CHEBI:85361


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: Microsatellite instability-high solid malignant tumor


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: chronic obstructive pulmonary disease


subject: HMDB:HMDB0001349

object_name: cardiovascular disorder


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:8768

object_name: gastritis


subject: CHEBI:8768

object_name: Gastritis, CTCAE


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: gastric ulcer


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732

object_name: duodenal ulcer


subject: CHEBI:3732

object_name: Duodenal Ulcer, CTCAE


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Helicobacter pylori infectious disease


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:30396

subject_name: phenyl group

object_name: chronic thromboembolic pulmonary hypertension


subject: UMLS:C0784217

subject_name: salt substitutes

object_name: end stage renal failure


subject: UMLS:C0784217

object_name: Chronic uremia


subject: UNII:HJT620308C

subject_name: SALT SUBSTITUTE


subject: UNII:HJT620308C


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: autosomal dominant polycystic kidney disease


subject: DRUGBANK:DB10640

object_name: coronary microvascular disorder


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Albuminuria


subject: UMLS:C5226663

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Hormone sensitive prostate cancer


subject: DRUGBANK:DB16515

object_name: sclerosing cholangitis


subject: DRUGBANK:DB16515

object_name: primary sclerosing cholangitis


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: coronary artery disorder


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:32150

object_name: cancer


subject: CHEBI:32150

object_name: neoplasm


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:15738

subject_name: Staurosporine


subject: CHEBI:15738


subject: MESH:D016324

subject_name: Sequence Tagged Sites


subject: MESH:D016324


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)


subject: CHEBI:75275


subject: CHEBI:18258

subject_name: Liothyronine

object_name: fibromyalgia


subject: UMLS:C2936843

subject_name: l-Triiodothyronine [EPC]


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: septic peritonitis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:HRE3327KCX

object_name: ovarian serous adenocarcinoma


subject: UMLS:C5706453

subject_name: SHP2 Inhibitor HS-10381

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: severe acute respiratory syndrome


subject: UNII:41XGO0VS1U

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: post-traumatic stress disorder


subject: CHEBI:30830

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:34967

subject_name: Rimonabant

object_name: Prader-Willi syndrome


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Ivermectin intoxication


subject: PUBCHEM.COMPOUND:6427057

object_name: Adverse drug response


subject: PUBCHEM.COMPOUND:6427057

object_name: Drug toxicity


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:6078


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: female reproductive organ cancer


subject: UNII:P0GVQ9A4S5

object_name: uterine cancer


subject: UNII:P0GVQ9A4S5

object_name: tumor of uterus


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:132082

subject_name: Entinostat

object_name: Carcinoma breast stage IV


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: thyroid gland carcinoma


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: Friedreich ataxia


subject: UNII:21K6M2I7AG

object_name: Friedreich ataxia 1


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: CHEBI:3756

subject_name: Clonazepam

object_name: burning mouth syndrome


subject: CHEBI:134729

subject_name: Dexrabeprazole

object_name: Non-erosive gastro-esophageal reflux disease


subject: UMLS:C0286475


subject: CHEBI:42567

subject_name: Fisetin

object_name: carpal tunnel syndrome 1


subject: CHEBI:42567

object_name: carpal tunnel syndrome


subject: UMLS:C1530204

object_name: HIV-1 infection


subject: UNII:Z46GXL23LX

subject_name: Oleylphosphocholine

object_name: leishmaniasis


subject: CHEBI:136040

subject_name: Levomilnacipran

object_name: endogenous depression


subject: CHEBI:136040

object_name: major depressive disorder


subject: CHEBI:135005

subject_name: Milnacipran


subject: CHEBI:135005


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Blast Phase


subject: CHEBI:52172

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:49375

subject_name: Dasatinib

object_name: Symptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Facial Expression


subject: CHEBI:8499

subject_name: Propranolol

object_name: age-related macular degeneration


subject: CHEBI:46858

subject_name: L-tyrosine residue

object_name: nemaline myopathy


subject: CHEBI:17895

subject_name: Tyrosine


subject: CHEBI:49375

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:49375

object_name: obesity


subject: CHEBI:49375

object_name: Obesity, CTCAE


subject: UMLS:C0963149

subject_name: Definity

object_name: melanoma


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:16335

subject_name: Adenosine

object_name: atrial fibrillation


subject: CHEBI:16335

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:16335

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:27732

subject_name: Caffeine

object_name: type 2 diabetes mellitus


subject: CHEBI:119486

subject_name: Efavirenz


subject: UNII:6897GXD6OE

object_name: systolic heart failure


subject: CHEBI:10983


subject: CHEBI:17066

subject_name: (R)-3-hydroxybutyric acid


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin

object_name: Androgen excess


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: CHEBI:15372

object_name: Isolated systolic hypertension


subject: CHEBI:15372

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: AIDS


subject: CHEBI:4911

subject_name: Etoposide

object_name: Kaposi Sarcoma


subject: CHEBI:141447

subject_name: Trp-Asn

object_name: West Nile fever


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: Uremic pruritus


subject: UNII:2P3VWU3H10

object_name: chronic kidney disease


subject: UNII:2P3VWU3H10

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:27594

subject_name: Graphite


subject: UMLS:C4489985

subject_name: Probiotic Blend Capsule


subject: UMLS:C4489985


subject: UMLS:C4489985


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin

object_name: hereditary endocrine growth disease


subject: PUBCHEM.COMPOUND:266052

object_name: iron deficiency anemia


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: PUBCHEM.COMPOUND:12901617

subject_name: Ginsenoside Rg3

object_name: Self efficacy (finding)


subject: CHEBI:133021

subject_name: Venetoclax

object_name: kidney disorder


subject: CHEBI:133021

object_name: kidney failure


subject: CHEBI:90936

subject_name: Alectinib

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:90936

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:90936

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:90936

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:3DGD69C6PV

subject_name: brigatinib


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: UNII:7DR7JMB8BH


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: CHEBI:29191

subject_name: hydroxyl

object_name: type 2 diabetes mellitus


subject: CHEBI:29191

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: UMLS:C0700307


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:16234


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C0021735

subject_name: Viraferon

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: ANTICOAGULATION (finding)


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C2348994

object_name: urothelial carcinoma


subject: UMLS:C2348994

object_name: transitional cell carcinoma


subject: UMLS:C2348994

object_name: bladder tumor


subject: UMLS:C2348994

object_name: urinary bladder carcinoma


subject: UMLS:C2348994

object_name: urinary bladder cancer


subject: UMLS:C2348994

object_name: childhood bladder carcinoma


subject: CHEBI:18248

subject_name: Iron

object_name: anemia deficiency iron treatment


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:31355

subject_name: Carboplatin

object_name: biliary tract neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J

object_name: endometrium neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C5557246

subject_name: KRAS G12C Inhibitor LY3537982

object_name: non-small cell lung carcinoma


subject: UMLS:C5557246

object_name: pancreatic neoplasm


subject: UMLS:C5557246


subject: UMLS:C5557246


subject: UMLS:C5557246

object_name: colorectal neoplasm


subject: UMLS:C5557246

object_name: ovarian cancer


subject: UMLS:C5557246

object_name: ovarian neoplasm


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:184662

object_name: Inflammation


subject: CHEBI:184662

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: colon carcinoma


subject: PR:000014196

object_name: colon cancer


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Pruritus, CTCAE


subject: CHEBI:2666

object_name: Pruritus


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:60791

subject_name: Xylocard


subject: CHEBI:60791


subject: CHEBI:8347

subject_name: Povidone-iodine

object_name: Anterior blepharitis


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: stroke disorder


subject: CHEBI:81579

object_name: cerebrovascular disorder


subject: CHEBI:81579

object_name: Stroke (heart beat)


subject: CHEBI:81579

object_name: Stroke, CTCAE


subject: CHEBI:50634

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: Vomiting in infants AND/OR children


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: familial avascular necrosis of femoral head


subject: CHEBI:47519

object_name: Pelvis fracture


subject: CHEBI:47519

object_name: Hip Fracture, CTCAE


subject: CHEBI:47519

object_name: hip fracture


subject: CHEBI:47519

object_name: osteoarthritis


subject: PR:000010536

subject_name: U3 small nucleolar ribonucleoprotein protein MPP10

object_name: hypogonadism


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin


subject: PUBCHEM.COMPOUND:57389748

object_name: endocrine system disorder


subject: PUBCHEM.COMPOUND:57389748

object_name: metabolic disease


subject: PUBCHEM.COMPOUND:57389748

object_name: respiratory system disorder


subject: PUBCHEM.COMPOUND:57389748

object_name: glucose metabolism disease


subject: CHEBI:32250

subject_name: tramadol hydrochloride

object_name: Headache


subject: CHEBI:32250

object_name: Headache, CTCAE


subject: CHEBI:32250

object_name: migraine


subject: CHEBI:32250

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:64312

subject_name: Memantine

object_name: cognitive/functional effects


subject: CHEBI:64312

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:64312

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:64312

object_name: Embolism, Tumor


subject: CHEBI:64312

object_name: Neoplasm Metastasis


subject: CHEBI:64312

object_name: neurotoxicity


subject: CHEBI:39585

subject_name: Carbidopa

object_name: acne


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: Stress urinary incontinence


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: RXCUI:151399

subject_name: Bactrim


subject: CHEBI:184472

subject_name: Nitrofurantoin


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: hyperlipidemia


subject: CHEBI:25681

object_name: hyperlipoproteinemia


subject: CHEBI:25681

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:25681

object_name: Serum lipids high (finding)


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Stress


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Level of stress


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Physiological Stress


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Stress (Psychology)


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Cumulative Stress, Psychological


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: kidney failure


subject: CHEBI:31632

object_name: Renal Failure, CTCAE


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: UMLS:C1145196


subject: CHEBI:61033

subject_name: Fondaparinux


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Metastatic Chordoma


subject: UNII:PQX0D8J21J

object_name: Unresectable Chordoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Hepatocellular Macrotrabecular Massive Carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: outcomes general quality of life


subject: UNII:M487QF2F4V

object_name: Perceived quality of life


subject: UNII:M487QF2F4V

object_name: Good quality of life


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:167312471

object_name: Hypercholesterolemia


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: Post-Traumatic Headache


subject: UNII:QY8BWX1LJ5

subject_name: Taladegib

object_name: Neoplasm Metastasis


subject: CHEBI:15864

subject_name: Luteolin

object_name: schizophrenia


subject: CHEBI:15864

object_name: schizoaffective disorder


subject: CHEBI:15864

object_name: schizophrenia 18


subject: CHEBI:57545


subject: CHEBI:57545


subject: CHEBI:57545


subject: UMLS:C0016018

subject_name: Fibrinolytic Agents

object_name: stroke disorder


subject: UMLS:C0016018

object_name: cerebrovascular disorder


subject: UMLS:C0016018

object_name: Stroke (heart beat)


subject: UMLS:C0016018

object_name: Stroke, CTCAE


subject: UMLS:C0016018

object_name: Procedural complication


subject: UMLS:C0016018

object_name: aortic valve disease 2


subject: UMLS:C0016018

object_name: aortic stenosis


subject: UMLS:C0016018

object_name: aortic valve disease 3


subject: UMLS:C0016018

object_name: Stenosis of aorta


subject: UMLS:C3536865

subject_name: Thrombolytic Agent [EPC]


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UMLS:C3536865


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: allergic; rhinitis, with asthma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: malignant peritoneal mesothelioma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: EGFR gene mutation


subject: UNII:T4RS462G19

subject_name: Almonertinib


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: melanoma


subject: UMLS:C4053572


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: pancreatic neoplasm


subject: UMLS:C4287707

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4287707

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:91668184

subject_name: Labetuzumab Govitecan

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:91668184

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:91668184

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:91668184

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:91668184

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:91668184

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:91668184

object_name: colon cancer


subject: UNII:8E3HI6QQ9J

subject_name: labetuzumab govitecan


subject: UNII:8E3HI6QQ9J


subject: UNII:8E3HI6QQ9J


subject: UNII:8E3HI6QQ9J


subject: UNII:8E3HI6QQ9J


subject: UNII:8E3HI6QQ9J


subject: UNII:8E3HI6QQ9J


subject: UMLS:C2987350

subject_name: ADC IMMU-130


subject: UMLS:C2987350


subject: UMLS:C2987350


subject: UMLS:C2987350


subject: UMLS:C2987350


subject: UMLS:C2987350


subject: UMLS:C2987350


subject: CHEBI:133658

subject_name: Leu-Gly


subject: CHEBI:133658


subject: CHEBI:133658


subject: CHEBI:133658


subject: CHEBI:133658


subject: CHEBI:133658


subject: CHEBI:133658


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: kidney failure


subject: UNII:CUJ2MVI71Y

object_name: kidney disorder


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: CHEBI:91872

object_name: Unresectable Soft Tissue Sarcoma


subject: CHEBI:91872

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:91872

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:91872

object_name: Liposarcoma metastatic


subject: CHEBI:91872

object_name: Metastatic fibrosarcoma


subject: CHEBI:91872

object_name: Metastatic angiosarcoma


subject: CHEBI:91872

object_name: Metastatic synovial sarcoma


subject: CHEBI:91872

object_name: Locally Advanced Liposarcoma


subject: CHEBI:91872

object_name: Metastatic myxofibrosarcoma


subject: CHEBI:91872

object_name: Epithelioid sarcoma metastatic


subject: CHEBI:91872

object_name: Locally Advanced Angiosarcoma


subject: CHEBI:91872

object_name: Locally Advanced Leiomyosarcoma


subject: CHEBI:91872

object_name: Malignant fibrous histiocytoma metastatic


subject: CHEBI:91872

object_name: Locally Advanced Myxofibrosarcoma


subject: CHEBI:91872

object_name: Locally Advanced Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:91872

object_name: undifferentiated embryonal sarcoma of the liver


subject: CHEBI:91872

object_name: undifferentiated (embryonal) sarcoma


subject: CHEBI:91872

object_name: Unresectable Synovial Sarcoma


subject: CHEBI:91872

object_name: Metastatic Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:91872

object_name: Locally Advanced Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:91872

object_name: Unresectable Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:91872

object_name: Unresectable Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:91872

object_name: Unresectable Liposarcoma


subject: CHEBI:91872

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:91872

object_name: pleomorphic rhabdomyosarcoma


subject: CHEBI:91872

object_name: adult pleomorphic rhabdomyosarcoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Unresectable Soft Tissue Sarcoma


subject: CHEBI:28748

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:28748

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:28748

object_name: Liposarcoma metastatic


subject: CHEBI:28748

object_name: Metastatic fibrosarcoma


subject: CHEBI:28748

object_name: Metastatic angiosarcoma


subject: CHEBI:28748

object_name: Locally Advanced Liposarcoma


subject: CHEBI:28748

object_name: Epithelioid sarcoma metastatic


subject: CHEBI:28748

object_name: Locally Advanced Angiosarcoma


subject: CHEBI:28748

object_name: Locally Advanced Leiomyosarcoma


subject: CHEBI:28748

object_name: Locally Advanced Myxofibrosarcoma


subject: CHEBI:28748

object_name: Locally Advanced Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:28748

object_name: undifferentiated embryonal sarcoma of the liver


subject: CHEBI:28748

object_name: undifferentiated (embryonal) sarcoma


subject: CHEBI:28748

object_name: Metastatic Malignant Peripheral Nerve Sheath Tumor